Current Advances on Non-Melanoma Skin Cancer • Constantin Caruntu Current Advances on Non-Melanoma Skin Cancer

Total Page:16

File Type:pdf, Size:1020Kb

Current Advances on Non-Melanoma Skin Cancer • Constantin Caruntu Current Advances on Non-Melanoma Skin Cancer Current Advances on Non-Melanoma on Cancer Skin Advances Current • Constantin Caruntu Current Advances on Non-Melanoma Skin Cancer Edited by Constantin Caruntu Printed Edition of the Special Issue Published in Journal of Clinical Medicine www.mdpi.com/journal/jcm Current Advances on Non-Melanoma Skin Cancer Current Advances on Non-Melanoma Skin Cancer Editor Constantin Caruntu MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade • Manchester • Tokyo • Cluj • Tianjin Editor Constantin Caruntu “Carol Davila” University of Medicine and Pharmacy Romania Editorial Office MDPI St. Alban-Anlage 66 4052 Basel, Switzerland This is a reprint of articles from the Special Issue published online in the open access journal Journal of Clinical Medicine (ISSN 2077-0383) (available at: https://www.mdpi.com/journal/jcm/ special issues/Non-Melanoma Skin Cancer). For citation purposes, cite each article independently as indicated on the article page online and as indicated below: LastName, A.A.; LastName, B.B.; LastName, C.C. Article Title. Journal Name Year, Volume Number, Page Range. ISBN 978-3-0365-0890-0 (Hbk) ISBN 978-3-0365-0891-7 (PDF) © 2021 by the authors. Articles in this book are Open Access and distributed under the Creative Commons Attribution (CC BY) license, which allows users to download, copy and build upon published articles, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. The book as a whole is distributed by MDPI under the terms and conditions of the Creative Commons license CC BY-NC-ND. Contents About the Editor .............................................. vii Preface to ”Current Advances on Non-Melanoma Skin Cancer” .................. ix Taxiarchis Konstantinos Nikolouzakis, Luca Falzone, Konstantinos Lasithiotakis, Sabine Kr uger-Krasagakis,¨ Alexandra Kalogeraki, Maria Sifaki, Demetrios A. Spandidos, Emmanuel Chrysos, Aristidis Tsatsakis and John Tsiaoussis Current and Future Trends in Molecular Biomarkers for Diagnostic, Prognostic, and Predictive Purposes in Non-Melanoma Skin Cancer Reprinted from: J. Clin. Med. 2020, 9, 2868, doi:10.3390/jcm9092868 ................. 1 Mircea Tampa, Simona Roxana Georgescu, Cristina Iulia Mitran, Madalina Irina Mitran, Clara Matei, Cristian Scheau, Carolina Constantin and Monica Neagu Recent Advances in Signaling Pathways Comprehension as Carcinogenesis Triggers in Basal Cell Carcinoma Reprinted from: J. Clin. Med. 2020, 9, 3010, doi:10.3390/jcm9093010 ................. 23 Paola Pasquali, Gonzalo Segurado-Miravalles, Mar Castillo, Angeles´ Fortu ˜no,Susana Puig and Salvador Gonz´alez Use of Cytology in the Diagnosis of Basal Cell Carcinoma Subtypes Reprinted from: J. Clin. Med. 2020, 9, 612, doi:10.3390/jcm9030612 ................. 39 Mihai Lupu, Iris Maria Popa, Vlad Mihai Voiculescu, Ana Caruntu and Constantin Caruntu A Systematic Review and Meta-Analysis of the Accuracy of in Vivo Reflectance Confocal Microscopy for the Diagnosis of Primary Basal Cell Carcinoma Reprinted from: J. Clin. Med. 2019, 8, 1462, doi:10.3390/jcm8091462 ................. 49 Andreea D. Lazar, Sorina Dinescu and Marieta Costache Deciphering the Molecular Landscape of Cutaneous Squamous Cell Carcinoma for Better Diagnosis and Treatment Reprinted from: J. Clin. Med. 2020, 9, 2228, doi:10.3390/jcm9072228 ................. 67 Ricardo Moreno, Laura N´ajera,Marta Mascaraque, Angeles´ Juarranz, Salvador Gonz´alezand Yolanda Gilaberte Influence of Serum Vitamin D Level in the Response of Actinic Keratosis to Photodynamic Therapy with Methylaminolevulinate Reprinted from: J. Clin. Med. 2020, 9, 398, doi:10.3390/jcm9020398 ................. 91 Mihai Lupu, Ana Caruntu, Daniel Boda and Constantin Caruntu In Vivo Reflectance Confocal Microscopy-Diagnostic Criteria for Actinic Cheilitis and Squamous Cell Carcinoma of the Lip Reprinted from: J. Clin. Med. 2020, 9, 1987, doi:10.3390/jcm9061987 .................101 v About the Editor Constantin Caruntu (MD, Ph.D.) is professor of Physiology at the “Carol Davila” University of Medicine and Pharmacy and is also a dermatologist at the “Prof. N. Paulescu” National Institute of Diabetes in Bucharest. He is trained in in vivo reflectance confocal microscopy, cellular and molecular biology techniques, and molecular imaging techniques. He is member of the International Dermoscopy Society, International League of Dermatological Societies, International Union of Physiological Sciences and many other national or international scientific societies. Furthermore, he is academic editor, guest editor and reviewer for various prestigious scientific journals. His research interests include in vivo reflectance confocal microscopy, dermato-oncology, inflammatory skin diseases, neurogenic inflammation and neuroendocrinology of the skin. vii Preface to ”Current Advances on Non-Melanoma Skin Cancer” Non-melanoma skin cancer (NMSC) comprises basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and several rare skin tumors and is the most common malignancy that affects humans worldwide. It accounts for the vast majority of skin cancers and a large percentage of all malignant tumors. Despite the growing public awareness and scientific interest regarding the risk of skin cancer, the incidence of NMSC is still rapidly increasing. Even if most NMSCs are associated with a less aggressive behavior, they can still be locally invasive and may produce extensive destruction of neighboring structures, inducing significant morbidity. Moreover, different types or subtypes of NMSCs are associated with frequent recurrence and may carry a significant metastatic potential. As a direct consequence, NMSC has become a major burden on healthcare systems with a significant socio-economic impact. Hence, there is no doubt as to why these keratinocyte-derived tumors are in the spotlight of scientific interest for both fundamental research and clinical practice. Consequently, this Special Issue brings together recent and relevant scientific research on NMSC. Studies regarding the complex inherited and environmental factors that can trigger tumor initiation and progression may offer a new perspective on skin cancer prevention. Investigation of new markers of skin carcinogenesis may contribute to the development of novel diagnostic, staging, and prognosis strategies for skin cancer and could lead to the design of more sophisticated and individually tailored treatment protocols. Improvements related to non-invasive or minimally invasive diagnostic tools and treatment methods may ameliorate the discomfort of patients while also reducing the costs associated with therapy. Moreover, the development of new techniques for the early diagnosis of NMSCs could reduce morbidity, ensuring more efficient treatment with better aesthetic and functional results. Constantin Caruntu Editor ix Journal of Clinical Medicine Review Current and Future Trends in Molecular Biomarkers for Diagnostic, Prognostic, and Predictive Purposes in Non-Melanoma Skin Cancer Taxiarchis Konstantinos Nikolouzakis 1,2, Luca Falzone 3, Konstantinos Lasithiotakis 2, Sabine Krüger-Krasagakis 4, Alexandra Kalogeraki 5, Maria Sifaki 6, Demetrios A. Spandidos 7, Emmanuel Chrysos 2, Aristidis Tsatsakis 6,* and John Tsiaoussis 1,* 1 Laboratory of Anatomy-Histology-Embryology, Medical School, University of Crete, 71110 Heraklion, Crete, Greece; [email protected] 2 Department of General Surgery, University General Hospital of Heraklion, 71110 Heraklion, Crete, Greece; [email protected] (K.L.); [email protected] (E.C.) 3 Epidemiology Unit, IRCCS Istituto Nazionale Tumori ‘Fondazione G. Pascale’, I-80131 Naples, Italy; [email protected] 4 Dermatology Department, University Hospital of Heraklion, 71110 Heraklion, Crete, Greece; [email protected] 5 Department of Pathology-Cytopathology, Medical School, University of Crete, 70013 Heraklion, Crete, Greece; [email protected] 6 Centre of Toxicology Science and Research, Faculty of Medicine, University of Crete, 71003 Heraklion, Crete, Greece; [email protected] 7 Laboratory of Clinical Virology, Medical School, University of Crete, 71003 Heraklion, Crete, Greece; [email protected] * Correspondence: [email protected] (A.T.); [email protected] (J.T.) Received: 3 August 2020; Accepted: 1 September 2020; Published: 4 September 2020 Abstract: Skin cancer represents the most common type of cancer among Caucasians and presents in two main forms: melanoma and non-melanoma skin cancer (NMSC). NMSC is an umbrella term, under which basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and Merkel cell carcinoma (MCC) are found along with the pre-neoplastic lesions, Bowen disease (BD) and actinic keratosis (AK). Due to the mild nature of the majority of NMSC cases, research regarding their biology has attracted much less attention. Nonetheless, NMSC can bear unfavorable characteristics for the patient, such as invasiveness, local recurrence and distant metastases. In addition, late diagnosis is relatively common for a number of cases of NMSC due to the inability to recognize such cases. Recognizing the need for clinically and economically efficient modes of diagnosis, staging, and prognosis, the present review discusses the main etiological and pathological features of NMSC as well as the new and promising molecular biomarkers available including telomere length (TL), telomerase activity (TA), CpG island methylation (CIM), histone methylation and acetylation, microRNAs (miRNAs), and micronuclei frequency (MNf). The
Recommended publications
  • Supplementary Materials
    Supplementary materials Supplementary Table S1: MGNC compound library Ingredien Molecule Caco- Mol ID MW AlogP OB (%) BBB DL FASA- HL t Name Name 2 shengdi MOL012254 campesterol 400.8 7.63 37.58 1.34 0.98 0.7 0.21 20.2 shengdi MOL000519 coniferin 314.4 3.16 31.11 0.42 -0.2 0.3 0.27 74.6 beta- shengdi MOL000359 414.8 8.08 36.91 1.32 0.99 0.8 0.23 20.2 sitosterol pachymic shengdi MOL000289 528.9 6.54 33.63 0.1 -0.6 0.8 0 9.27 acid Poricoic acid shengdi MOL000291 484.7 5.64 30.52 -0.08 -0.9 0.8 0 8.67 B Chrysanthem shengdi MOL004492 585 8.24 38.72 0.51 -1 0.6 0.3 17.5 axanthin 20- shengdi MOL011455 Hexadecano 418.6 1.91 32.7 -0.24 -0.4 0.7 0.29 104 ylingenol huanglian MOL001454 berberine 336.4 3.45 36.86 1.24 0.57 0.8 0.19 6.57 huanglian MOL013352 Obacunone 454.6 2.68 43.29 0.01 -0.4 0.8 0.31 -13 huanglian MOL002894 berberrubine 322.4 3.2 35.74 1.07 0.17 0.7 0.24 6.46 huanglian MOL002897 epiberberine 336.4 3.45 43.09 1.17 0.4 0.8 0.19 6.1 huanglian MOL002903 (R)-Canadine 339.4 3.4 55.37 1.04 0.57 0.8 0.2 6.41 huanglian MOL002904 Berlambine 351.4 2.49 36.68 0.97 0.17 0.8 0.28 7.33 Corchorosid huanglian MOL002907 404.6 1.34 105 -0.91 -1.3 0.8 0.29 6.68 e A_qt Magnogrand huanglian MOL000622 266.4 1.18 63.71 0.02 -0.2 0.2 0.3 3.17 iolide huanglian MOL000762 Palmidin A 510.5 4.52 35.36 -0.38 -1.5 0.7 0.39 33.2 huanglian MOL000785 palmatine 352.4 3.65 64.6 1.33 0.37 0.7 0.13 2.25 huanglian MOL000098 quercetin 302.3 1.5 46.43 0.05 -0.8 0.3 0.38 14.4 huanglian MOL001458 coptisine 320.3 3.25 30.67 1.21 0.32 0.9 0.26 9.33 huanglian MOL002668 Worenine
    [Show full text]
  • Pan-Proteomic Approaches to Diseases
    ANNUAL MEETING ABSTRACTS 433A were Grade 2. The CD45 labeling indices for Grade 1 and 2 tumors were 7.4 ± 19.7% of cyst fluid tumor marker is variable. Recently, molecular tests of cyst fluid have been and 4.7 ± 11.1% (p=0.47). The Ki-67+/CD45+ labeling indices for Grade 1 and 2 tumors applied and show high specificity in the differentiation of the pancreatic cystic lesions. were 0.0029 ± 0.10% and 0.60 ± 3.6% (p=0.45). In this study, we investigated the usefulness of molecular analysis of pancreatic cyst Conclusions: These results suggest that tumor-infiltrating lymphocytes did not affect fluid in the setting of inconclusive cytology and non-contributory tumor markers test. the Ki-67 labeling index in this series of PanNETs, and will require validation with a Design: We retrospectively reviewed pancreatic cystic lesions with EUS-FNA cytology, larger patient population. cyst fluid tumor markers (CEA and amylase) and molecular tests (K-ras mutation and loss of heterozygocity) from 2009-2011. The inconclusive cytology diagnosis was 1802 MicroRNAs as Diagnostic Markers for Pancreatic Ductal defined as “non-diagnostic” or “atypical cytology”. Non-contributory cyst fluid chemical Adenocarcinoma and Pancreatic Intraepithelial Neoplasm analysis includes 2 situations: 1) amylase<250U/L and CEA <192 ng/ml or 2) amylase >250 U/L and CEA >192ng/ml. The molecular tests and the histopathologic results of Y Xue, AN Abou Tayoun, KM Abo, JM Pipas, SR Gordon, TB Gardner, RJ Barth, AA the resection specimens were analyzed. Suriawinata, GJ Tsongalis. Dartmouth-Hitchcock Medical Center, Lebanon, NH.
    [Show full text]
  • Download Special Issue
    BioMed Research International Integrated Analysis of Multiscale Large-Scale Biological Data for Investigating Human Disease 2016 Guest Editors: Tao Huang, Lei Chen, Jiangning Song, Mingyue Zheng, Jialiang Yang, and Zhenguo Zhang Integrated Analysis of Multiscale Large-Scale Biological Data for Investigating Human Disease 2016 BioMed Research International Integrated Analysis of Multiscale Large-Scale Biological Data for Investigating Human Disease 2016 GuestEditors:TaoHuang,LeiChen,JiangningSong, Mingyue Zheng, Jialiang Yang, and Zhenguo Zhang Copyright © 2016 Hindawi Publishing Corporation. All rights reserved. This is a special issue published in “BioMed Research International.” All articles are open access articles distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Contents Integrated Analysis of Multiscale Large-Scale Biological Data for Investigating Human Disease 2016 Tao Huang, Lei Chen, Jiangning Song, Mingyue Zheng, Jialiang Yang, and Zhenguo Zhang Volume 2016, Article ID 6585069, 2 pages New Trends of Digital Data Storage in DNA Pavani Yashodha De Silva and Gamage Upeksha Ganegoda Volume 2016, Article ID 8072463, 14 pages Analyzing the miRNA-Gene Networks to Mine the Important miRNAs under Skin of Human and Mouse Jianghong Wu, Husile Gong, Yongsheng Bai, and Wenguang Zhang Volume 2016, Article ID 5469371, 9 pages Differential Regulatory Analysis Based on Coexpression Network in Cancer Research Junyi
    [Show full text]
  • Regulation of the Cortical Actin Cytoskeleton in Budding Yeast by Twinfilin, a Ubiquitous Actin Monomer-Sequestering Protein Bruce L
    Regulation of the Cortical Actin Cytoskeleton in Budding Yeast by Twinfilin, a Ubiquitous Actin Monomer-sequestering Protein Bruce L. Goode, David G. Drubin, and Pekka Lappalainen Department of Molecular and Cell Biology, University of California, Berkeley, California 94720-3202 Abstract. Here we describe the identification of a cells, a green fluorescent protein (GFP)–twinfilin fu- novel 37-kD actin monomer binding protein in budding sion protein localizes primarily to cytoplasm, but also to yeast. This protein, which we named twinfilin, is com- cortical actin patches. Overexpression of the twinfilin posed of two cofilin-like regions. In our sequence data- gene (TWF1) results in depolarization of the cortical base searches we also identified human, mouse, and actin patches. A twf1 null mutation appears to result in Caenorhabditis elegans homologues of yeast twinfilin, increased assembly of cortical actin structures and is suggesting that twinfilins form an evolutionarily con- synthetically lethal with the yeast cofilin mutant cof1- served family of actin-binding proteins. Purified recom- 22, shown previously to cause pronounced reduction in binant twinfilin prevents actin filament assembly by turnover of cortical actin filaments. Taken together, forming a 1:1 complex with actin monomers, and inhib- these results demonstrate that twinfilin is a novel, its the nucleotide exchange reaction of actin monomers. highly conserved actin monomer-sequestering protein Despite the sequence homology with the actin filament involved in regulation of the cortical actin cytoskeleton. depolymerizing cofilin/actin-depolymerizing factor (ADF) proteins, our data suggests that twinfilin does Key words: actin • cytoskeleton • budding yeast • not induce actin filament depolymerization. In yeast twinfilin • cofilin HE actin cytoskeleton plays an essential role in mul- aments.
    [Show full text]
  • Molecular Characterization of Mutant Mouse Strains Generated from the EUCOMM/KOMP-CSD ES Cell Resource
    Mamm Genome DOI 10.1007/s00335-013-9467-x Molecular Characterization of Mutant Mouse Strains Generated from the EUCOMM/KOMP-CSD ES Cell Resource Edward Ryder • Diane Gleeson • Debarati Sethi • Sapna Vyas • Evelina Miklejewska • Priya Dalvi • Bishoy Habib • Ross Cook • Matthew Hardy • Kalpesh Jhaveri • Joanna Bottomley • Hannah Wardle-Jones • James N. Bussell • Richard Houghton • Jennifer Salisbury • William C. Skarnes • Sanger Mouse Genetics Project • Ramiro Ramirez-Solis Received: 3 April 2013 / Accepted: 27 June 2013 Ó The Author(s) 2013. This article is published with open access at Springerlink.com Abstract The Sanger Mouse Genetics Project generates Introduction knockout mice strains using the EUCOMM/KOMP-CSD embryonic stem (ES) cell collection and characterizes the The extensive genetic resources available for the mouse, consequences of the mutations using a high-throughput including the sequencing and annotation of the genomes of primary phenotyping screen. Upon achieving germline multiple inbred laboratory strains (Church et al. 2009; transmission, new strains are subject to a panel of quality Keane et al. 2011; Flicek et al. 2012; Wong et al. 2012), control (QC) PCR- and qPCR-based assays to confirm the have facilitated comprehensive comparisons with the correct targeting, cassette structure, and the presence of the human genome (Guigo et al. 2003; Zheng-Bradley et al. 30 LoxP site (required for the potential conditionality of the 2010; Mouse ENCODE Consortium et al. 2012). This allele). We report that over 86 % of the 731 strains studied makes the mouse a powerful tool for both investigating showed the correct targeting and cassette structure, of gene function and modelling disease progression in mam- which 97 % retained the 30 LoxP site.
    [Show full text]
  • UNIVERSITY of CALIFORNIA, SAN DIEGO Measuring
    UNIVERSITY OF CALIFORNIA, SAN DIEGO Measuring and Correlating Blood and Brain Gene Expression Levels: Assays, Inbred Mouse Strain Comparisons, and Applications to Human Disease Assessment A dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Biomedical Sciences by Mary Elizabeth Winn Committee in charge: Professor Nicholas J Schork, Chair Professor Gene Yeo, Co-Chair Professor Eric Courchesne Professor Ron Kuczenski Professor Sanford Shattil 2011 Copyright Mary Elizabeth Winn, 2011 All rights reserved. 2 The dissertation of Mary Elizabeth Winn is approved, and it is acceptable in quality and form for publication on microfilm and electronically: Co-Chair Chair University of California, San Diego 2011 iii DEDICATION To my parents, Dennis E. Winn II and Ann M. Winn, to my siblings, Jessica A. Winn and Stephen J. Winn, and to all who have supported me throughout this journey. iv TABLE OF CONTENTS Signature Page iii Dedication iv Table of Contents v List of Figures viii List of Tables x Acknowledgements xiii Vita xvi Abstract of Dissertation xix Chapter 1 Introduction and Background 1 INTRODUCTION 2 Translational Genomics, Genome-wide Expression Analysis, and Biomarker Discovery 2 Neuropsychiatric Diseases, Tissue Accessibility and Blood-based Gene Expression 4 Mouse Models of Human Disease 5 Microarray Gene Expression Profiling and Globin Reduction 7 Finding and Accessible Surrogate Tissue for Neural Tissue 9 Genetic Background Effect Analysis 11 SPECIFIC AIMS 12 ENUMERATION OF CHAPTERS
    [Show full text]
  • Analyzing the Mirna-Gene Networks to Mine the Important Mirnas Under Skin of Human and Mouse
    Hindawi Publishing Corporation BioMed Research International Volume 2016, Article ID 5469371, 9 pages http://dx.doi.org/10.1155/2016/5469371 Research Article Analyzing the miRNA-Gene Networks to Mine the Important miRNAs under Skin of Human and Mouse Jianghong Wu,1,2,3,4,5 Husile Gong,1,2 Yongsheng Bai,5,6 and Wenguang Zhang1 1 College of Animal Science, Inner Mongolia Agricultural University, Hohhot 010018, China 2Inner Mongolia Academy of Agricultural & Animal Husbandry Sciences, Hohhot 010031, China 3Inner Mongolia Prataculture Research Center, Chinese Academy of Science, Hohhot 010031, China 4State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China 5Department of Biology, Indiana State University, Terre Haute, IN 47809, USA 6The Center for Genomic Advocacy, Indiana State University, Terre Haute, IN 47809, USA Correspondence should be addressed to Yongsheng Bai; [email protected] and Wenguang Zhang; [email protected] Received 11 April 2016; Revised 15 July 2016; Accepted 27 July 2016 Academic Editor: Nicola Cirillo Copyright © 2016 Jianghong Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Genetic networks provide new mechanistic insights into the diversity of species morphology. In this study, we have integrated the MGI, GEO, and miRNA database to analyze the genetic regulatory networks under morphology difference of integument of humans and mice. We found that the gene expression network in the skin is highly divergent between human and mouse.
    [Show full text]
  • The Genetics of Deafness in Domestic Animals
    REVIEW published: 08 September 2015 doi: 10.3389/fvets.2015.00029 The genetics of deafness in domestic animals George M. Strain * Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, USA Although deafness can be acquired throughout an animal’s life from a variety of causes, hereditary deafness, especially congenital hereditary deafness, is a significant problem in several species. Extensive reviews exist of the genetics of deafness in humans and mice, but not for deafness in domestic animals. Hereditary deafness in many species and breeds is associated with loci for white pigmentation, where the cochlear pathology is cochleo-saccular. In other cases, there is no pigmentation association and the cochlear pathology is neuroepithelial. Late onset hereditary deafness has recently been identi- fied in dogs and may be present but not yet recognized in other species. Few genes responsible for deafness have been identified in animals, but progress has been made Edited by: for identifying genes responsible for the associated pigmentation phenotypes. Across Edward E. Patterson, University of Minnesota College of species, the genes identified with deafness or white pigmentation patterns include MITF, Veterinary Medicine, USA PMEL, KIT, EDNRB, CDH23, TYR, and TRPM1 in dog, cat, horse, cow, pig, sheep, Reviewed by: ferret, mink, camelid, and rabbit. Multiple causative genes are present in some species. D. Colette Williams, Veterinary Medical Teaching Hospital Significant work remains in many cases to identify specific chromosomal deafness genes at the University of California Davis, so that DNA testing can be used to identify carriers of the mutated genes and thereby USA Dennis P.
    [Show full text]
  • Book of Abstracts, GTH, Bremen 2020;
    64th Annual Meeting Society of Thrombosis and Haemostasis Research Novel concepts for a lifetime challenge Bremen, Germany |18–21 February 2020 Book of Abstracts WELCOME ADDRESS Dear colleagues and friends, our congress motto “Novel concepts for a lifetime challenge” points out that many disorders in the field of thrombosis and haemostasis affect patients throughout their entire life. Thus, basic science and patient care should involve both, an interdisciplinary approach at a patient’s given age and a close collaboration of physicians and scientists specialised on different phases of the patient’s life, such as neonatologists, paediatricians, general practitioners and geriatricians. Understanding the natural history of bleeding and thrombotic disorders from a clinical and scientific perspective is key to providing our patients with the best possible treatment in a rapidly changing landscape of novel diagnostic tests and therapeutic agents. We feel that the Town Musicians of Bremen, as depicted in the annual meeting’s logo, nicely illustrate the urgent need for trustful teamwork in basic science and clinical practice. Only when we build on each other’s knowledge and experience, we can come up with “Novel concepts for a lifetime challenge”. We have received many outstanding contributions on a broad spectrum of basic and clinical research topics and hope that you enjoy reading the annual meeting's abstracts as much as we did! Florian Langer Thomas Renné Congress president Congress president Bremen, Germany |18–21 February 2020 / © GTH Society
    [Show full text]
  • A Quantitative Genetic Analysis of Limb Segment Morphology in Humans and Other Primates: Genetic Variance, Morphological Integration, and Linkage Analysis
    University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Doctoral Dissertations Graduate School 5-2016 A Quantitative Genetic Analysis of Limb Segment Morphology in Humans and Other Primates: Genetic Variance, Morphological Integration, and Linkage Analysis Brannon Irene Hulsey University of Tennessee - Knoxville, [email protected] Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss Part of the Biological and Physical Anthropology Commons Recommended Citation Hulsey, Brannon Irene, "A Quantitative Genetic Analysis of Limb Segment Morphology in Humans and Other Primates: Genetic Variance, Morphological Integration, and Linkage Analysis. " PhD diss., University of Tennessee, 2016. https://trace.tennessee.edu/utk_graddiss/3710 This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. To the Graduate Council: I am submitting herewith a dissertation written by Brannon Irene Hulsey entitled "A Quantitative Genetic Analysis of Limb Segment Morphology in Humans and Other Primates: Genetic Variance, Morphological Integration, and Linkage Analysis." I have examined the final electronic copy of this dissertation for form and content and recommend that it be accepted in partial fulfillment of the equirr ements for the degree of Doctor of Philosophy, with a major in Anthropology. Graciela S. Cabana, Major Professor We have read this dissertation and recommend its acceptance: Benjamin M. Auerbach, Lorena M. Havill, Andrew Kramer, Richard L. Jantz, Charles C. Roseman, Arnold M. Saxton Accepted for the Council: Carolyn R.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2011/0098188 A1 Niculescu Et Al
    US 2011 0098188A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2011/0098188 A1 Niculescu et al. (43) Pub. Date: Apr. 28, 2011 (54) BLOOD BOMARKERS FOR PSYCHOSIS Related U.S. Application Data (60) Provisional application No. 60/917,784, filed on May (75) Inventors: Alexander B. Niculescu, Indianapolis, IN (US); Daniel R. 14, 2007. Salomon, San Diego, CA (US) Publication Classification (51) Int. Cl. (73) Assignees: THE SCRIPPS RESEARCH C40B 30/04 (2006.01) INSTITUTE, La Jolla, CA (US); CI2O I/68 (2006.01) INDIANA UNIVERSITY GOIN 33/53 (2006.01) RESEARCH AND C40B 40/04 (2006.01) TECHNOLOGY C40B 40/10 (2006.01) CORPORATION, Indianapolis, IN (52) U.S. Cl. .................. 506/9: 435/6: 435/7.92; 506/15; (US) 506/18 (57) ABSTRACT (21) Appl. No.: 12/599,763 A plurality of biomarkers determine the diagnosis of psycho (22) PCT Fled: May 13, 2008 sis based on the expression levels in a sample Such as blood. Subsets of biomarkers predict the diagnosis of delusion or (86) PCT NO.: PCT/US08/63539 hallucination. The biomarkers are identified using a conver gent functional genomics approach based on animal and S371 (c)(1), human data. Methods and compositions for clinical diagnosis (2), (4) Date: Dec. 22, 2010 of psychosis are provided. Human blood Human External Lines Animal Model External of Evidence changed in low vs. high Lines of Evidence psychosis (2pt.) Human postmortem s Animal model brai brain data (1 pt.) > Cite go data (1 p. Biomarker For Bonus 1 pt. Psychosis Human genetic 2 N linkage? association A all model blood data (1 pt.) data (1 p.
    [Show full text]
  • Affymetrix Probe ID Gene Symbol 1007 S at DDR1 1494 F At
    Affymetrix Probe ID Gene Symbol 1007_s_at DDR1 1494_f_at CYP2A6 1552312_a_at MFAP3 1552368_at CTCFL 1552396_at SPINLW1 /// WFDC6 1552474_a_at GAMT 1552486_s_at LACTB 1552586_at TRPV3 1552619_a_at ANLN 1552628_a_at HERPUD2 1552680_a_at CASC5 1552928_s_at MAP3K7IP3 1552978_a_at SCAMP1 1553099_at TIGD1 1553106_at C5orf24 1553530_a_at ITGB1 1553997_a_at ASPHD1 1554127_s_at MSRB3 1554152_a_at OGDH 1554168_a_at SH3KBP1 1554217_a_at CCDC132 1554279_a_at TRMT2B 1554334_a_at DNAJA4 1554480_a_at ARMC10 1554510_s_at GHITM 1554524_a_at OLFM3 1554600_s_at LMNA 1555021_a_at SCARF1 1555058_a_at LPGAT1 1555197_a_at C21orf58 1555282_a_at PPARGC1B 1555460_a_at SLC39A6 1555559_s_at USP25 1555564_a_at CFI 1555594_a_at MBNL1 1555729_a_at CD209 1555733_s_at AP1S3 1555906_s_at C3orf23 1555945_s_at FAM120A 1555947_at FAM120A 1555950_a_at CD55 1557137_at TMEM17 1557910_at HSP90AB1 1558027_s_at PRKAB2 1558680_s_at PDE1A 1559136_s_at FLJ44451 /// IDS 1559490_at LRCH3 1562378_s_at PROM2 1562443_at RLBP1L2 1563522_at DDX10 /// LOC401533 1563834_a_at C1orf62 1566509_s_at FBXO9 1567214_a_at PNN 1568678_s_at FGFR1OP 1569629_x_atLOC389906 /// LOC441528 /// LOC728687 /// LOC729162 1598_g_at GAS6 /// LOC100133684 200064_at HSP90AB1 200596_s_at EIF3A 200597_at EIF3A 200604_s_at PRKAR1A 200621_at CSRP1 200638_s_at YWHAZ 200640_at YWHAZ 200641_s_at YWHAZ 200702_s_at DDX24 200742_s_at TPP1 200747_s_at NUMA1 200762_at DPYSL2 200872_at S100A10 200878_at EPAS1 200931_s_at VCL 200965_s_at ABLIM1 200998_s_at CKAP4 201019_s_at EIF1AP1 /// EIF1AX 201028_s_at CD99 201036_s_at HADH
    [Show full text]